Identification of HBV and HCV transmission in multi-transfused Thalassemia patients of Azad Jammu and Kashmir, Pakistan

Background: Thalassemia patients need regular blood transfusion which saves their lives but increases the risk of acquiring viral infections like hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Objective(s): This study aimed to screen out the HCV and HBV infections in Thalassemia patients receiving regular blood in three centers of Azad Jammu and Kashmir (AJK), Pakistan. Materials and Methods: It was a cross sectional, multicenter study involving 224 Thalassemia patients. The study was carried out from August 2019 to January 2020 in Thalassemia centers of Sheikh Khalifa Bin Zaid hospital Rawalakot, District Headquarters hospital (DHQ) Palandari, and Combined Military Hospital (CMH) Muzaffarabad, AJK. A total of 224 patients were screened out for HCV and HBV. Indirect ELISA was carried out to detect anti HCV antibodies while direct ELISA was carried out to detect the HBsAg from all the samples using commercially available ELISA kits. Results: Overall, 12 patients (5.36%) were found to be positive for HBV while 63 (28.1%) were positive for HCV. HBV positive patients included 7 (5.69%) males and 5 (4.95%) females while HCV positive patients included 26 (41.27%) males and 37 (58.73%) female patients. Both the viruses were more common among elder patients as compared to younger patients. Conclusion: Prevalence of HCV is very high and that of HBV is moderately high among Thalassemia patients of AJK.


Introduction
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are currently two of the major killers of human being all over the world. It is estimated that about 400 million people are infected with HBV and 200 million with HCV all around the globe [1][2][3].
HBV and HCV are highly prevalent in Pakistan as about 10 million people are infected with HBV and another 10 million are infected with HCV [4][5]. Both of the HBV and HCV are blood borne viruses and transmitted through blood transfusion, injections, surgical instruments, dental procedures, piercing, tattooing, tooth brushes, razors, pedicuring equipments, menicuring equipments and other invasive practices. Moreover, it has also been reported that both the viruses can be transmitted from infected mother to newborn which is called vertical transmission while HBV is also transmitted through sexual contacts [6][7][8][9]. Both the HBV and HCV cause liver damage. They lead to chronic liver disease, cirrhosis, hepatocellular carcinoma (HCC), end stage liver disease and death and are the most common transfusion transmitted infections (5,(10)(11).
Thalasseamia is a group of genetic disorders which is majorly divided into alpha-thalassemia and beta thalassemia [12]. Βeta-thalassemia is the most prevalent genetic problem worldwide and its carrier rate in Pakistan is about 5-7% [13].This is an autosomal recessive disorder characterized by reduced or absent beta globin chain [12].
Thalassemia patients need regular blood transfusion for maintaining their hemoglobin level [14].Regular blood transfusion in these patients saves their lives but increases the risk of acquiring viral infections like hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) (14)(15). So, these patients have a great risk of obtaining HCV, HBV, HIV and other infections as compared to the normal population [14][15]. Although, the blood screening before transfusion is a . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint normal practice now, still the transmission of viruses occurs even from healthy blood donors. Moreover, the patients sometimes receive blood from professional blood donors when the blood is needed urgently [16][17].
The aim of current study was to find out the prevalence of both HCV and HBV in blood receiving thalassemia patients from three thalassemia centers of AJK, as enough scientific literature is not available on topic from the region of AJK, Pakistan.
. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint

Study Duration, Design and Settings
This was a multicenter cross sectional study carried out from August 2019 to January 2020 in Thalassemia centers of Sheikh Khalifa Bin Zaid hospital Rawalakot, District Headquarters hospital (DHQ) Palandari, and Combined Military Hospital (CMH) Muzaffarabad, AJK.

Inclusion and Exclusion Criteria
Thalassemia patients who were receiving blood in any of the selected hospitals having no known HCV or HBV infection in their family were included in the study.

Patients Enrolment
A total of 224 thalassemia patients, regularly receiving blood in the selected hospitals, who met the inclusion criteria, were enrolled in the study. Out of these, 81

Patient's Data Collection
The relevant data of risk factors was collected on a prescribed proforma. The factors included: patient's blood group, age, gender, period of blood transfusion, source of blood, parent's relationship, and cast of the patient.

Sample Collection and Screening
Blood samples were taken with the help of 5 ml sterile syringes in EDTA coated tubes from all patients. The serum was separated by centrifugation at 3000 rpm for five minutes and stored at -20 o C for further analysis. Blood samples of all the patients were . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint 6 subjected to Enzyme Linked Immuno Sorbant Essay (ELISA). Indirect ELISA was carried out to detect anti-HCV antibodies while direct ELISA was carried out to detect HBsAg using commercially available ELISA kits following the manufacturers protocol (Genway Biotech, United Kingdom).

Statistical Analysis
All the data was entered and analyzed in Statistical Package for Social Sciences (SPSS) version 16.0. Chi square test was applied for qualitative comparisons where needed.

Ethical Approval and Informed Consent
The study was approved by "human and animals ethics committee", university of Poonch Rawalakot AJK. An informed consent form was filled and signed by each participant before the start of blood screening. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

Overall and Center Wise Prevalence
The copyright holder for this this version posted January 25, 2022.  (Table 2).

Age wise Prevalence
In present study, the mean age of patients was calculated to be 7.51± 4.67 years, ranging from 1-18 years. The patients were divided into three age groups. The first group comprised of the patients of 1 to 6 years and there were 118 patients in this age group. Out of these 118 patients, 3 (2.54%) were positive for HBV and all were present in Muzaffarabad center while 16 (13.56%) were positive for HCV which included 2 (1.7%) in Rawalakot, 5 (4.2%) in Palandari and 9 (7.6%) in Muzaffarabad center (Table 3). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint Second group included patients from 7 to 12 years in which 72 patients were present. Out these 72 patients, 6 (8.33 %) were positive for HBV including 2 (2.78%) in Rawalakot and 4 (5.55%) in Muzaffarabad while 23 (31.94%) were positive for HCV including 7 (9.7%) in Rawalakot center, 8 (11.1%) in Palandari and 8 (11.1%) in Muzaffarabad center (Table 3). There was a significant difference of both HCV and HBV infection (P < 0.05) among the age groups as the older age patients had significantly higher percentage of both infections as compared to younger patients. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint

Discussion
Blood transfusion is the important risk factor for the transmission of viruses like HIV, HBV and HCV. Thalassemia patients require regular blood transfusion for survival and have always a high risk of getting these infections. The present study was aimed to calculate the prevalence of HBV and HCV infections in three thalassemia centers of the state of Azad Jammu and Kashmir. The study included 224 thalassemia patients who were screened for hepatitis C and B viruses. The prevalence of these viruses was found to be 28.1% and 5.36% respectively. Overall prevalence of HCV was higher than that of HBV. Almost similar results were also reported previously in a study from Pakistan who reported HCV in 29% and HBV in 8% of the thalassemia patients [18]. Another study conducted in Pakistan reported that 39% of thalassemia patients are infected with HCV and 5% with HBV [19]. However, a very high prevalence of HCV among thalassemia patients in Pakistan (55%) was reported in another earlier study [20]. So, the thalassemia patients in Pakistan are highly infected with HCV and moderately with HBV.
On the base of present study and previous literature, it is observed that infection rate of HCV and HBV in thalassemia patients is very high in Pakistan and AJK when compared with some of the nearby countries like Iran, Iraq and Palestine, as the infection percentage of HCV and HBV in thalassemia patients was reported to be 3.8% and 3.8% respectively in Iran, 3.8% and 2.5% respectively in Iraq, and 10% and <1% respectively in Palestine [21][22][23]. The fact that thalassemia patients of Pakistan and AJK have very high HCV infection and a moderate HBV infections may be linked with the fact that prevalence of HCV is already high and that of HBV is also moderate . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint to high in general population of Pakistan and AJK [24][25][26]. The prevalence of both HCV and HBV is very high in Pakistan when compared to advanced countries like Germany where the prevalence of both viruses ranges from 0.2% to 1.9% [27]. So, the prevalence of HCV and HBV in thalassemia patients of the region corresponds to the prevalence of these infections in general population. However, it is much higher than the prevalence in general population which seems because of the high risk posed by multiple blood transfusions to these patients and lack of standard blood screening system prior to transfusion. This fact is also supported by the observation that the patients with more transfusions have more prevalence than those with less transfusions received (Table 3).
Overpopulation, poverty and lack of resources are some more factors possibly contributing towards the high prevalence of HCV and HBV in thalassemia patients of the country which limit the blood screening tests to low price only, and in turn, allow the viral infections to pass along with blood to the patients. Besides these, another fact that matters reasonably is the selection of blood donors. In case of thalassemia patients who often need blood urgently, the donor is not always been selected by some special criteria, but the blood is received from anyone ready to donate or even sometime is purchased from professional blood donors who may be injectable drug users (IDUs).
Collectively, because of low resources and shorter time, the proper and up-to the standards screening may not be possible in the region to control efficiently the transfusion transmitted viruses.
The prevalence of HCV and HBV was found to be significantly higher in older age patients as compared to those of younger age (Table 3). This finding may be . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint associated with the fact that the older patients have lived more age with thalassemia and received more blood transfusions than the younger ones. As, higher the number of transfusion more will be the exposure to viruses and risk of infection, the elder patients are likely to have more infection than the younger patients who received less blood.
Similar findings and reasons have been previously reported too [22,26].
The highest prevalence of HCV was found in Muzaffarabad followed by Palandari and then Rawalakot. The prevalence of HBV was also higher in the patients of Muzaffarabad center as compared to the patients in Rawalakot and Palandari centers. The center wise differences of HCV and HBV prevalence may be because of the local differences of HBV and HCV prevalence in these areas or may be because of some differences in screening procedure or because of some unknown reasons.
Currently, no study or other published literature is available to confirm any fact or reason of these differences. More studies may provide some better explanation.
Current research shows the alarming situation of HCV and HBV transmission in thalassemia patients through blood transfusion in the area of AJK, Pakistan. The results will guide the healthcare professionals and the thalassemia patients to screen the blood before transfusion using more efficient methods. It may influence the policy of blood transfusion in the area and lead to hepatitis control strategies. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint

Conclusions
The current study concludes that HCV infection is very high (28.1%) while HBV is moderately high (5.36%) in thalassemia patients of the region of Azad Jammu and Kashmir, Pakistan. The prevalence is higher as compared to the prevalence of these viruses in other countries. Moreover, the prevalence of the viruses is higher in older age patients as compared to younger patients.

Acknowledgment
Miss Saba Nosheen and Miss Sumayya Siddique are acknowledged for their role in data collection.
. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01.25.22269811 doi: medRxiv preprint